Home | Welcome to Contract Pharma   
Last Updated Tuesday, April 28 2015


Financial Report: Patheon

Published March 8, 2013
1Q Revenues: $213.5 million (+39%)
1Q Loss: $51.4 million (loss of $19.3 million 1Q12)
Comments: Banner contributed $23.3 million to growth in the quarter. Patheon standalone revenues grew 24%. CMO revenues increased 47% to $180.1 million. Pharmaceutical Development Services' (PDS) revenues increased 7% to $33.4 million. The increase in loss was due to costs associated with the Banner acquisition and related refinancing.

blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On